ClinicalTrials.Veeva

Menu

Safety and Feasibility of Fasting While Receiving Chemotherapy

K

King Fahad Medical City

Status

Completed

Conditions

Chemotherapy
Cancer
Fasting

Study type

Observational

Funder types

Other

Identifiers

NCT00757094
KFMC IRB-08-040

Details and patient eligibility

About

Fasting (refraining from eating and drinking) during the day is safe while receiving chemotherapy.

Enrollment

12 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age > 18 years
  • Established diagnosis of cancer
  • Signed informed consent
  • Adequate CBC and chemistry to receive chemotherapy

Exclusion criteria

  • Pregnancy

Trial design

12 participants in 1 patient group

I
Description:
Patients planning to observe fasting while receiving chemotherapy during the month of Ramadan

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems